Hata Shoji, Namae Misako, Nishina Hiroshi
Department of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.
Dev Growth Differ. 2007 Feb;49(2):163-70. doi: 10.1111/j.1440-169X.2007.00910.x.
The liver has an unusual capacity to regenerate after a loss of mass and function caused by surgical resection or toxic liver injury. Over the last 10 years there have been major advances in our understanding of the molecular and cellular mechanisms underlying liver development and regeneration. The numerous factors crucial to these phenomena have been identified mainly by using knockout mice. Forward-genetics studies using zebrafish and medaka have also generated many mutants with liver disorders or defects in liver formation. Our goal is to translate knowledge gained from laboratory work and animal models into novel therapies for human liver diseases. Exciting progress has been achieved using human partial liver transplantation and autologous cell therapy.
肝脏在因手术切除或中毒性肝损伤导致质量和功能丧失后,具有非凡的再生能力。在过去十年中,我们对肝脏发育和再生的分子及细胞机制的理解取得了重大进展。对这些现象至关重要的众多因素主要是通过使用基因敲除小鼠来确定的。利用斑马鱼和青鳉进行的正向遗传学研究也产生了许多患有肝脏疾病或肝脏形成缺陷的突变体。我们的目标是将从实验室工作和动物模型中获得的知识转化为治疗人类肝脏疾病的新疗法。使用人类部分肝移植和自体细胞疗法已取得了令人兴奋的进展。